Ludocare
Evidence-based digital therapies that improve adherence and overall health of children with chronic conditions.
Evidence-based digital therapies that improve adherence and overall health of children with chronic conditions.
Ludocare is a French start-up founded in 2017 with a vision to revolutionize the management of chronic diseases in children. The company's flagship product, JOE, is a digital therapy device that focuses on optimizing pediatric asthma management through correct inhalation techniques and treatment adherence. Ludocare has gained recognition for its expertise and impact, with prestigious accolades such as iLab, iNov, and Big Booster. The company received a significant €4.20M Seed Round investment on 04 July 2022 from Bpifrance and Karista. With a commitment to developing clinically validated solutions, supporting children with chronic diseases and their families, and contributing to the future of digital health, Ludocare exemplifies innovation in the Health Care, Health and Wellness, and Care Economy industries. Through an evidence-based approach and personalized support, Ludocare aims to enhance the lives of young patients and improve the overall management of their conditions.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €4.20M | 2 |
|
04 Jul 2022 |
No recent news or press coverage available for Ludocare.
We care about your data, and we'd love to use cookies make your experience better.
